**Bombshell Findings Reveal Excess DNA Contamination in COVID-19 Vaccines**
In a stunning revelation that calls into question the safety protocols surrounding COVID-19 vaccinations, a recent study conducted by scientists at the U.S. Food and Drug Administration (FDA) has uncovered significant DNA contamination in Pfizer’s mRNA vaccine.
The independent research, which was published in the Journal of High School Science, showed that residual DNA levels in the vaccine exceeded regulatory safety limits by an astonishing 6 to 470 times.
This alarming data raises grave concerns over the regulatory practices that allowed such contaminated vials to be distributed to the public.
Conducted by student researchers under the supervision of FDA scientists, the study utilized sophisticated testing methods such as NanoDrop and Qubit analyses. These methods are essential in measuring DNA and RNA contamination, ultimately confirming that the levels of DNA found in the vaccine far surpass permissible thresholds.
Former director of the Human Genome Project, Kevin McKernan, labeled the findings a “bombshell.” He criticized the FDA for its lack of transparency and questioned why the agency failed to report these concerning data to the public.
“This could signal a serious risk to public health,” McKernan stated, emphasizing that chronic exposure to foreign DNA from vaccines may have unintended consequences, including an increased likelihood of cancer development.
He highlighted that previous attempts to downplay concerns regarding DNA contamination should be thoroughly reconsidered in light of this new evidence. The toxic ramifications of unchecked viral DNA in vaccines are not just speculative; serious efforts must be made to evaluate their implications on long-term health outcomes.
Compounding the controversy, traces of the SV40 promoter—a known virus in primates that raises concerns about tumor formation—were also detected in the DNA fragments examined. While acknowledging the researchers’ assessments, McKernan urged for a more rigorous analysis to fully understand the implications of these findings.
The FDA has yet to issue an official comment regarding this critical study, nor have they disclosed plans to alert the public or recall the affected vaccine batches. This lack of action only fuels skepticism regarding the agency's commitment to ensuring public safety and transparency in its oversight processes.
Critics argue that the failure to act decisively in the face of such shocking findings could further erode public trust in medical authorities, particularly as many Americans remain wary after previous controversies surrounding vaccine efficacy and safety.
The responsibility now lies with the FDA to clarify these findings and urgently reassess its regulatory procedures.
Without decisive action, the potential ramifications of this contamination scandal may not only jeopardize public health but also impact confidence in the broader vaccination efforts moving forward.
As America gears up for potential future health crises, ensuring that regulatory agencies prioritize transparency and safety will be paramount. The revelations from this FDA study provide a crucial opportunity for reform, emphasizing the need for rigorous oversight in the development and deployment of vaccines—products that millions depend on for their health and safety.
Sources:
globalresearch.caglobalresearch.caglobalresearch.ca